Literature DB >> 20618507

Interferon-induced vitiligo in hepatitis C patients: a case series.

Issam Hamadah1, Yousef Binamer, Faisal M Sanai, Ayman A Abdo, Abdulmajeed Alajlan.   

Abstract

BACKGROUND: Vitiligo is an autoimmune disease characterized by depigmented patches and macules. It is associated with many autoimmune diseases, the most common of which is thyroid disease. The association between Interferon (IFN) therapy and vitiligo is rarely reported in the literature, despite its common usage in hepatitis B viral infection, hepatitis C viral infection (HCV), hematological malignancies and melanoma. CASE: We are reporting eight cases of vitiligo that appeared after treating HCV with IFN.
CONCLUSION: Interferon unmasks vitiligo in susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618507     DOI: 10.1111/j.1365-4632.2009.04443.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Vitiligo at Injection Site of PEG-IFN-α 2a in Two Patients with Chronic Hepatitis C: Case Report and Literature Review.

Authors:  V Arya; M Bansal; L Girard; S Arya; A Valluri
Journal:  Case Rep Dermatol       Date:  2010-08-27

2.  Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy.

Authors:  Kamuran Turker; Betul Tas; Murat Ozkaya; Ebru Tas; Aysel Caglar; Umit Seza Tetikkurt
Journal:  Hepat Mon       Date:  2015-03-20       Impact factor: 0.660

3.  IFN‑γ induces apoptosis in human melanocytes by activating the JAK1/STAT1 signaling pathway.

Authors:  Qianya Su; Fei Wang; Zhengbang Dong; Mei Chen; Rong Cao
Journal:  Mol Med Rep       Date:  2020-08-03       Impact factor: 2.952

4.  Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease.

Authors:  Esra Guney; Gulunay Akcali; Betul Ilkay Akcay; Cihan Unlu; Gurkan Erdogan; Tahir Kansu Bozkurt; Huseyin Bayramlar
Journal:  Case Rep Med       Date:  2012-08-16

5.  Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy.

Authors:  Rebecca L Riding; Jillian M Richmond; Keitaro Fukuda; John E Harris
Journal:  Pigment Cell Melanoma Res       Date:  2020-10-26       Impact factor: 4.159

Review 6.  Concise review of recent studies in vitiligo.

Authors:  Mohamed Allam; Hassan Riad
Journal:  Qatar Med J       Date:  2013-12-23

7.  Observational descriptive study of cutaneous manifestations in patients from Mato Grosso with viral chronic hepatitis.

Authors:  Renato Roberto Liberato Rostey; Francisco José Dutra Souto
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

8.  A direct link between MITF, innate immunity, and hair graying.

Authors:  Melissa L Harris; Temesgen D Fufa; Joseph W Palmer; Sandeep S Joshi; Denise M Larson; Arturo Incao; Derek E Gildea; Niraj S Trivedi; Autumne N Lee; Chi-Ping Day; Helen T Michael; Thomas J Hornyak; Glenn Merlino; William J Pavan
Journal:  PLoS Biol       Date:  2018-05-03       Impact factor: 8.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.